Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Oxygenta Pharmaceutical Annual Report

Oxygenta Pharmaceutical has submitted its 33rd Annual Report for FY 2025-26, including the notice for the upcoming Annual General Meeting scheduled for August 21, 2026.

Source

BSE filing, NSE: SSORGS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Oxygenta Pharmaceutical Ltd: key numbers

Share price
₹47.96
Market cap
₹177.4 Cr
Revenue (annual)
₹113.0 Cr
Net profit (annual)
₹-17.57 Cr
P/E (TTM)
-13.1×Sector 46.1×
Promoter holding
56.54%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Oxygenta Pharmaceutical Ltd

All →

Other annual report announcements

All →